Wolf‐Rüdiger Ulrich

Author

Wolf‐Rüdiger Ulrich

Klinikum Konstanz

Also Known As

W R Ulrich, W Ulrich, W. R. Ulrich, W.-R. Ulrich, W.R. Ulrich, Wolf-Rüdiger Ulrich, Wolf‐Rüdiger Ulrich

Publications

952

Citations

H-Index

Concepts

All Affiliations

Klinikum Konstanz University of Konstanz MS-Schramberg (Germany)

About

Wolf‐Rüdiger Ulrich is an author at Klinikum Konstanz specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	504
2	Biochemistry	2	2	52
3	Natural Sciences	1	1	33
4	Biomolecular Engineering	1	1	19
5	Cell Biology	1	1	18

Wolf‐Rüdiger Ulrich

Publications

833

Citations

H-Index

Page 1

	Year	Citations
The Leukotriene LTD4 Receptor Antagonist Mk571 Specifically Modulates MRP Associated Multidrug Resistance Volker Gekeler, W Ise, Karl H. Sanders, Biochemical and Biophysical Research Communications InflammationMolecular PharmacologyAnti-inflammatoryOxysterolFunctional Selectivity	1995	405
The Inhibitory Potency and Selectivity of Arginine Substrate Site Nitric-Oxide Synthase Inhibitors Is Solely Determined by Their Affinity toward the Different Isoenzymes Rainer Boer, Wolf‐Rüdiger Ulrich, Thomas Klein, Molecular Pharmacology	2000	154
The Novel Imidazopyridine 2-[2-(4-Methoxy-pyridin-2-yl)-ethyl]-3H-imidazo[4,5-b]pyridine (BYK191023) Is a Highly Selective Inhibitor of the Inducible Nitric-Oxide Synthase Andreas Strub, Wolf‐Rüdiger Ulrich, Christian Heßlinger, Molecular Pharmacology	2005	35
Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights Ulrich Grädler, Thomas Fuchß, Wolf‐Rüdiger Ulrich, Bioorganic & Medicinal Chemistry Letters Medicinal ChemistryPharmaceutical ChemistryBiochemistryReactive Nitrogen SpecieNatural Sciences	2011	33
Characterization of the Dexniguldipine Binding Site in the Multidrug Resistance-Related Transport Protein P-Glycoprotein by Photoaffinity Labeling and Mass Spectrometry Christoph H. Borchers, Rainer Boer, Kurt Klemm, Molecular Pharmacology	2002	33
Stereoselective inhibition of thromboxane‐induced coronary vasoconstriction by 1,4‐dihydropyridine calcium channel antagonists Manfrid Eltze, Karl H. Sanders, Hildegard Boss, Chirality	1990	31
Reversible Labeling of a Chemosensitizer Binding Domain of p-Glycoprotein with a Novel 1,4-Dihydropyridine Drug Transport Inhibitor<sup>,</sup> R. Boer, Manfred Dichtl, Christoph H. Borchers, Biochemistry	1996	31
In vitro and in vivo uroselectivity of B8805-033, an antagonist with high affinity at prostatic α 1A - vs. α 1B - and α 1D -adrenoceptors Manfrid Eltze, Rainer Boer, Martin C. Michel, Naunyn-Schmiedeberg s Archives of Pharmacology Molecular PharmacologyUrologyMedicinePhysiologyExperimental Pharmacology	2001	29
B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein. Christoph H. Borchers, Wolf‐Rüdiger Ulrich, Kurt Klemm, Molecular Pharmacology	1995	21
Interaction of cytostatics and chemosensitizers with the dexniguldipine binding site on P-glycoprotein Rainer Boer, Wolf‐Rüdiger Ulrich, Sabine Haas, European Journal of Pharmacology BiochemistryG Protein-coupled ReceptorDrug DiscoveryGlycobiologyBiochemical Interaction	1996	19

Page 1